Newbridge Financial Services Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3K | Sell |
73
-4
| -5% | -$2.1K | 0.01% | 560 |
|
|
2025
Q1 | $48.8K | Buy |
77
+2
| +3% | +$1.27K | 0.01% | 374 |
|
|
2024
Q4 | $53.4K | Sell |
75
-76
| -50% | -$54.1K | 0.01% | 389 |
|
|
2024
Q3 | $159K | Buy |
151
+10
| +7% | +$10.5K | 0.06% | 173 |
|
|
2024
Q2 | $148K | Sell |
141
-2
| -1% | -$2.1K | 0.06% | 220 |
|
|
2024
Q1 | $138K | Buy |
143
+41
| +40% | +$39.5K | 0.06% | 242 |
|
|
2023
Q4 | $89.6K | Sell |
102
-10
| -9% | -$8.78K | 0.04% | 293 |
|
|
2023
Q3 | $92.2K | Sell |
112
-24
| -18% | -$19.8K | 0.05% | 314 |
|
|
2023
Q2 | $97.7K | Sell |
136
-26
| -16% | -$18.7K | 0.05% | 320 |
|
|
2023
Q1 | $133K | Hold |
162
| – | – | 0.07% | 267 |
|
|
2022
Q4 | $117K | Sell |
162
-30
| -16% | -$21.6K | 0.07% | 272 |
|
|
2022
Q3 | $132K | Sell |
192
-7
| -4% | -$4.81K | 0.08% | 249 |
|
|
2022
Q2 | $118K | Sell |
199
-108
| -35% | -$64K | 0.07% | 245 |
|
|
2022
Q1 | $214K | Buy |
307
+181
| +144% | +$126K | 0.11% | 190 |
|
|
2021
Q4 | $80K | Buy |
126
+34
| +37% | +$21.6K | 0.04% | 355 |
|
|
2021
Q3 | $56K | Sell |
92
-900
| -91% | -$548K | 0.04% | 383 |
|
|
2021
Q2 | $554K | Sell |
992
-397
| -29% | -$222K | 0.34% | 62 |
|
|
2021
Q1 | $657K | Sell |
1,389
-45
| -3% | -$21.3K | 0.48% | 40 |
|
|
2020
Q4 | $693K | Buy |
1,434
+230
| +19% | +$111K | 0.57% | 36 |
|
|
2020
Q3 | $674K | Buy |
+1,204
| New | +$674K | 0.66% | 28 |
|